|
HMGB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.111800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.072400E-01 |
| Normal-vs-Stage2 |
5.920000E-01 |
| Normal-vs-Stage3 |
5.136800E-01 |
| Normal-vs-Stage4 |
6.185600E-01 |
| Stage1-vs-Stage2 |
7.649000E-01 |
| Stage1-vs-Stage3 |
1.301830E-01 |
| Stage1-vs-Stage4 |
1.788040E-01 |
| Stage2-vs-Stage3 |
3.453000E-01 |
| Stage2-vs-Stage4 |
4.033600E-01 |
| Stage3-vs-Stage4 |
7.941800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.099000E-01 |
| Normal-vs-AfricanAmerican |
8.033800E-01 |
| Normal-vs-Asian |
4.875000E-01 |
| Caucasian-vs-AfricanAmerican |
7.087000E-01 |
| Caucasian-vs-Asian |
5.656400E-01 |
| AfricanAmerican-vs-Asian |
4.290400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.626200E-01 |
| Normal-vs-Female |
8.256400E-01 |
| Male-vs-Female |
8.095800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.837400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.777800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.243200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.087200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.613800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.585400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.206200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.981000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.445170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.642800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.384410E-02 |
| Normal-vs-Grade 2 |
9.975700E-02 |
| Normal-vs-Grade 3 |
2.496800E-01 |
| Normal-vs-Grade 4 |
7.099700E-02 |
| Grade 1-vs-Grade 2 |
2.195800E-01 |
| Grade 1-vs-Grade 3 |
1.028490E-04 |
| Grade 1-vs-Grade 4 |
3.350200E-04 |
| Grade 2-vs-Grade 3 |
2.564100E-04 |
| Grade 2-vs-Grade 4 |
2.007800E-04 |
| Grade 3-vs-Grade 4 |
2.150800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.770300E-02 |
| Normal-vs-ccB subtype |
9.856100E-02 |
| ccA subtype-vs-ccB subtype |
4.89709999995647E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.408600E-01 |
| Normal-vs-N1 |
2.560600E-01 |
| N0-vs-N1 |
3.710400E-01 |
|
|
